118 related articles for article (PubMed ID: 26924327)
1. Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA.
Palomino-Morales R; Perales S; Torres C; Linares A; Alejandre MJ
Curr Vasc Pharmacol; 2016; 14(4):345-52. PubMed ID: 26924327
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
[TBL] [Abstract][Full Text] [Related]
3. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages.
Luan Z; Chase AJ; Newby AC
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):769-75. PubMed ID: 12663370
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.
Serra N; Rosales R; Masana L; Vallvé JC
PLoS One; 2015; 10(7):e0133875. PubMed ID: 26207907
[TBL] [Abstract][Full Text] [Related]
5. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells.
Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR
Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307
[TBL] [Abstract][Full Text] [Related]
6. Increased RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells by lovastatin.
Von Zee CL; Richards MP; Bu P; Perlman JI; Stubbs EB
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2816-23. PubMed ID: 19151402
[TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxymethyl coenzyme A reductase inhibition attenuates spontaneous smooth muscle tone via RhoA/ROCK pathway regulated by RhoA prenylation.
Rattan S
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G962-9. PubMed ID: 20378830
[TBL] [Abstract][Full Text] [Related]
8. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
[TBL] [Abstract][Full Text] [Related]
9. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
[TBL] [Abstract][Full Text] [Related]
10. ROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodeling.
Chapados R; Abe K; Ihida-Stansbury K; McKean D; Gates AT; Kern M; Merklinger S; Elliott J; Plant A; Shimokawa H; Jones PL
Circ Res; 2006 Oct; 99(8):837-44. PubMed ID: 16990566
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells.
Li X; Liu L; Tupper JC; Bannerman DD; Winn RK; Sebti SM; Hamilton AD; Harlan JM
J Biol Chem; 2002 May; 277(18):15309-16. PubMed ID: 11839765
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of extracellular matrix production and remodeling by doxycycline in smooth muscle cells.
Palomino-Morales R; Torres C; Perales S; Linares A; Alejandre MJ
J Pharmacol Sci; 2016 Dec; 132(4):218-223. PubMed ID: 27107823
[TBL] [Abstract][Full Text] [Related]
13. HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells.
Ito T; Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Shimada K
Cardiovasc Drugs Ther; 2002 Mar; 16(2):121-6. PubMed ID: 12090904
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation.
Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J
Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313
[TBL] [Abstract][Full Text] [Related]
15. The role of geranylgeranylated proteins in human mesangial cell proliferation.
Khwaja A; Sharpe CC; Noor M; Hendry BM
Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
[TBL] [Abstract][Full Text] [Related]
17. Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells.
Rombouts K; Kisanga E; Hellemans K; Wielant A; Schuppan D; Geerts A
J Hepatol; 2003 May; 38(5):564-72. PubMed ID: 12713866
[TBL] [Abstract][Full Text] [Related]
18. Modulation of COX-2 expression by statins in human aortic smooth muscle cells. Involvement of geranylgeranylated proteins.
Degraeve F; Bolla M; Blaie S; Créminon C; Quéré I; Boquet P; Lévy-Toledano S; Bertoglio J; Habib A
J Biol Chem; 2001 Dec; 276(50):46849-55. PubMed ID: 11591701
[TBL] [Abstract][Full Text] [Related]
19. HMG-CoA reductase inhibitor lovastatin causes reversible cytoskeleton perturbation by RhoA signalling suppression in peritoneal cell line Met5A.
Suzuki N; Imai A
J Obstet Gynaecol; 2010 May; 30(4):404-7. PubMed ID: 20455727
[TBL] [Abstract][Full Text] [Related]
20. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling.
Zhong WB; Liang YC; Wang CY; Chang TC; Lee WS
Endocr Relat Cancer; 2005 Sep; 12(3):615-29. PubMed ID: 16172195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
